in past times few years, the UK has witnessed a revolution in clinical body weight‑loss treatment plans — within the introduction of semaglutide (Wegovy®) towards the increasing acceptance of tirzepatide (Mounjaro®). Now, One more title is drawing awareness in both equally clinical and community